Merck immune system-booster effective in skin, lung cancer

(Reuters) - A highly anticipated new immunotherapy from Merck & Co Inc proved effective in patients with advanced melanoma as well as some with lung cancer or head and neck cancer, according to early-stage studies presented on Monday.

via Reuters: Health News Read More Here..